Life Sciences (International Firms) | Greater China Region

Ropes & Gray LLP houses a highly reputed life sciences practice which offers expertise in both regulatory and transactional matters, as well as related IP and FCPA issues. The team advises US and Asian companies on their Chinese operations and cross-border matters, including licensing and collaboration agreements. It is active on M&A and financing projects for a strong roster of pharmaceutical, biotechnology and medical device companies. The firm counts Pediatrix Therapeutics, Zenas BioPharma and Tianjin Adicon among its key clients.

Sidley Austin LLP fields a top-notch team handling a range of work in the life science space, including transactions, FCPA investigations and antitrust matters as well as related IP issues. It is particularly skilled in undertaking licensing as well as financing matters. The team advises international companies on corporate, regulatory and compliance issues. The firm is also active on matters relating to data privacy. Its enviable clientele featuresNeuroFront Therapeutics (Hong Kong), Rona Therapeutics and I-Mab Biopharma.

Arnold & Porter's growing life sciences team maintains an active practice by engaging with well-known pharmaceutical and medical device clients. It is able to advise across the spectrum of life sciences mandates and offers particular regulatory strength in enforcement and compliance-related issues. The team is well placed to handle investigations, litigation and cross-border transactional work on behalf of life sciences companies. The firm is additionally noted for its specialism in product liability matters. Its impressive client roster includes Thermo Fisher, Agilent and Zimmer Biomet.

Bird & Bird's life sciences and healthcare team is recognised for its strength in contentious and non-contentious IP issues, including patent litigation, licensing and portfolio management. The team advises on clinical trials and is increasingly active on corporate and transactional matters. It is adept at handling regulatory and data transfer issues. It acts for an impressive roster of medical device, pharmaceutical and biotech companies, including startups, government and research bodies such as Edwards Lifesciences, Merck KGaA and Stryker Pacific. The firm is noted for its capabilities in cross-border matters involving Asian and European jurisdictions.

Cooley LLP's life sciences department is a strong transactional outfit that advises pharmaceutical and biotechnology companies. The team is sought after by investors for assistance on acquisitions, investments, M&A and licensing agreements. Its additional strengths include advice on joint venture formation and cross-border capital markets transactions as well as regulatory matters. Its clientele features Asymchem Laboratories, Full-Life Technologies and Jacobio Pharmaceuticals.

Goodwin's has a burgeoning practice in life sciences, actively advising on a wide range of transactional matters, including financings and investments. In addition to regulatory advice, it is well versed at handling licensing and partnership agreements. The firm fields a group of experts with previous experience as scientists. Its core clientele features well-known entities, including Biotheus, Duality Biologics and Jemincare.

The robust life sciences and healthcare team at Hogan Lovells has a broad offering with expertise in IP, commercial agreements, business restructuring, M&A transactions, product liability and compliance issues. Its significant experience is in handling regulatory matters relating to the growing fields of digital health and telemedicine. The team retains a strong client base among international pharmaceutical and medical device companies. The firm also has noteworthy expertise advising on clinical trials, investigations as well as litigations.

The China life sciences department at Morrison Foerster LLP possesses strong technical abilities and broad industrial experience. Its key areas of focus include IP and due diligence matters. The team advises clients on IP prosecution and portfolio management. It is well versed at handling corporate matters including outbound investments, commercial partnerships, joint ventures and M&A deals. The firm counts a number of public and private companies, as well as investment firms, among its clients, including Jiangsu Hengrui Medicine and Triastek.

DLA Piper LLP's life sciences team skilfully provides a fully rounded and globally integrated life science practice, ranging from corporate/M&A, employment and capital markets to investigations. Its partners in Hong Kong and Shanghai cater to clients from all areas of life science including pharmaceuticals, biotechnology and medical devices. The team is also active on regulatory issues, data protection and IP work for its life sciences clientele. Aesthetic Medical International Holding Group, Blue Ocean Structure Investment and Arlington Capital Partners are among the firm's clients.

Keller and Heckman LLP possesses especially strong expertise in food and packaging industries throughout Asia-Pacific. It is adept at advising on a variety of compliance and regulatory matters such as labelling, obtaining clearance and approval for food ingredients, drugs and medical devices. The practice is increasingly active in mandates in connection with plant-based and cell-based foods. Its specialist team is noted for including scientists and lawyers with scientific backgrounds who assist clients entering the China market. The team is also active on regulatory work in the chemicals, health food, confectionery and e-tobacco products sectors. Its key clients include Perfect Day, ChromaDex and Omya.

Norton Rose Fulbright houses an active life sciences and healthcare team that offers expertise in regulatory, IP and commercialisation matters including licensing, patent and trade mark prosecution and litigation. The team handles corporate work such as M&A transactions and joint ventures in addition to litigation and other types of dispute resolution. It acts for an impressive list of leading global pharmaceutical and healthcare corporations as well as private equity firms, such as Pfizer, GlaxoSmithKline (GSK) and Tillotts Pharma.